Glaxo Eyes Human Genome Sciences for $2.6 Billion
16 Juillet 2012 - 1:10AM
Dow Jones News
GlaxoSmithKline PLC (GSK, GSK.LN) is in talks to acquire Human
Genome Sciences Inc. (HGSI) in a $2.6 billion deal, Reuters reports
on its website Sunday, citing "sources familiar with the
situation."
Citing one of the sources, Reuters reported that GlaxoSmithKline
could sweeten the deal slightly, and that an announcement could
come as early as Monday.
A spokesman from GlaxoSmithKline declined to comment, Reuters
said, adding Human Genome Sciences officials were not immediately
available.
Full story at
http://www.reuters.com/article/2012/07/15/us-humangenome-glaxosmithkline-idUSBRE8
E08P20120715
-Write to copydesk@dowjones.com
Human Genome Sciences (NASDAQ:HGSI)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Human Genome Sciences (NASDAQ:HGSI)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about Human Genome Sciences, Inc. (MM) (NASDAQ): 0 recent articles
Plus d'articles sur Human Genome Sciences Inc.